Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Biocon Biologics recognized as Asia IP Elite for 2025 by IAM

Biocon in collaboration with Equillium begins Itolizumab clinical study for Ulcerative Colitis in India

Ruchika Sharma15 Dec 2022 5:00 PM IST

Itolizumab is a clinical-stage, first-in-class anti-CD6 monoclonal antibody that selectively targets the CD6- ALCAM pathway, which can drive several...

JB Pharma forays into Statin segment, acquires Razel franchise from Glenmark for Rs 314 crore

Ruchika Sharma15 Dec 2022 4:00 PM IST

New Delhi: JB Pharma, one of the fastest growing pharmaceutical companies in India, has entered into an agreement with Glenmark Pharmaceuticals...

Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspection

Jubilant Pharmova gets 8 USFDA obervations for Nanjangud facility

Ruchika Sharma15 Dec 2022 3:00 PM IST

Noida: Jubilant Pharmova Limited has recently announced that the United States Food and Drug Administration (USFDA) has issued eight observations...

AstraZeneca India names Dr Sanjeev Panchal as Country President, MD

Ruchika Sharma15 Dec 2022 2:00 PM IST

Sanjeev is currently the Country President for AstraZeneca Malaysia.

SII Cervical cancer vaccine CERVAVAC likely to be launched in April next year

Ruchika Sharma15 Dec 2022 1:00 PM IST

Serum Institute's vaccine is likely to be available at a much lower rate.

Great Place to Work Institute names Baxter Healthcare India among Top 15 India's Best Workplaces in Pharmaceuticals, Healthcare, and Biotech 2022

Ruchika Sharma15 Dec 2022 12:00 PM IST

New Delhi: Baxter Healthcare in India has been recognised by the Great Place to Work Institute as one of the Top 15 Best Workplaces in...

Shukra Pharma Signs MoU With US Firm for AI Surgical Robotics in India

Eli Lilly, EVA Pharma collaborate to provide affordable insulin to diabetic patients in Africa

Ruchika Sharma15 Dec 2022 11:00 AM IST

Indianapolis: Eli Lilly and Company and EVA Pharma have announced a collaboration to deliver a sustainable supply of high-quality,...

Torrent Pharma collaborates with Boehringer Ingelheim India to co-market its anti-diabetic drug, its fixed dose combinations in India

Ruchika Sharma14 Dec 2022 4:50 PM IST

Ahmedabad: Torrent Pharmaceuticals Ltd has entered into a strategic alliance with Boehringer Ingelheim India Private Limited to co-market Cospiaq...

Novartis Loses India Patent on Heart Failure Drug Vymada

Novartis prostate cancer therapy Pluvicto bags European Commission nod

Ruchika Sharma14 Dec 2022 4:15 PM IST

"The approval of Pluvicto by the European Commission marks a major milestone for patients with advanced prostate cancer who have few alternative...

Eli Lilly hopes to launch as many as 5 new treatments next year

Ruchika Sharma14 Dec 2022 3:15 PM IST

Indianapolis: Eli Lilly and Co said on Tuesday it hopes to launch as many as five new treatments next year that could drive growth through the decade...

Boehringer Ingelheim gets European Commission approval for Generalized Pustular Psoriasis flares treatment Spesolimab

Ruchika Sharma14 Dec 2022 2:15 PM IST

People living with GPP often do not receive a correct or timely diagnosis and may have their symptoms identified as other forms of psoriasis.

Bharat Serums and Vaccines bags exclusive right to market severe burns treatment NexoBrid in India

Ruchika Sharma14 Dec 2022 1:15 PM IST

Mumbai: Bharat Serums and Vaccines Limited (BSV) a biopharmaceutical company in India has entered into an exclusive distribution agreement with...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok